![](https://globalnews.ca/wp-content/uploads/2024/08/GettyImages-2167186138.jpg?quality=85&strip=all&w=720&h=379&crop=1)
1st lung cancer vaccine trials launch, powered by COVID mRNA technology
The mRNA revolution continues. Just a few years after mRNA vaccines proved their efficacy against COVID-19, scientists are now turning their attention to lung cancer. The mRNA vaccine, known as BTN116, developed by the German biotechnology company BioNTech …